Thus, the anti-VEGFR-1 mAb was able to reduce the invasive response of melanoma cells to PlGF, as well their adhesion to sVEGFR-1, both mechanisms that contribute to trigger the spread of B16F10 cells through the tumor microenvironment. This evidence concerns the gene PGF and neoplasm.